Literature DB >> 23234873

Wrist actigraphy predicts outcome in patients with pulmonary hypertension.

Silvia Ulrich1, Manuel Fischler, Rudolf Speich, Konrad E Bloch.   

Abstract

BACKGROUND: Pulmonary hypertension (PH) impairs quality of life, exercise performance and survival. Simple measures to monitor the disease are needed.
OBJECTIVES: We tested whether actigraphy by a wrist-worn device in the patient's home reflects disease severity in PH patients.
METHODS: Twenty-three outpatients with pulmonary arterial and chronic thromboembolic PH (15 females), functional classes II-IV, underwent clinical examination and actigraphy over 2 weeks while pursuing their usual life at home. Actigraphies were correlated with clinical data and mean pulmonary artery pressure (mPAP). Deaths, lung transplantations and pulmonary endarterectomy were recorded over 4 years.
RESULTS: Actigraphies revealed a mean ± SD daytime activity duration of 14:57 ± 1:14 h with 146 ± 125 activity counts/min. Very severely impaired patients (mPAP 50 ± 7 mm Hg) were inactive for longer periods at night (8:25 ± 1:18 h) and less active during the day (54 ± 44 counts/min) when compared to modestly impaired patients (mPAP 33 ± 7 mm Hg; inactive at night for 6:58 ± 0:39 h; daytime activity 229 ± 148 counts/min, p < 0.05 in all instances). Out of 19 patients followed for 4 years, 5 died and 1 received a lung transplantation. Kaplan-Meier analysis revealed a shorter survival without lung transplantation in patients with a duration of daytime activity of <15 h/day than those with >15 h/day duration (log rank, p = 0.026).
CONCLUSION: A long nocturnal rest and reduced daytime activity recorded by actigraphy are associated with severe hemodynamic impairment and reduced survival in patients with PH. Therefore, wrist actigraphy performed during everyday life in the patient's home holds promise as a simple tool for the assessment of disease severity and prognosis in patients with PH.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2012        PMID: 23234873     DOI: 10.1159/000342351

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  10 in total

Review 1.  Reliable and developmentally appropriate study end points are needed to achieve drug development for treatment of pediatric pulmonary arterial hypertension.

Authors:  H Sun; N Stockbridge; R L Ariagno; D Murphy; R M Nelson; W Rodriguez
Journal:  J Perinatol       Date:  2016-07-14       Impact factor: 2.521

2.  Counting Steps: A New Way to Monitor Patients with Pulmonary Arterial Hypertension.

Authors:  Sameep Sehgal; Ananda Chowdhury; Fadi Rabih; Abhishek Gadre; Margaret M Park; Manshi Li; Xiaofeng Wang; Kristin B Highland
Journal:  Lung       Date:  2019-05-29       Impact factor: 2.584

3.  Physical activity in incident patients with pulmonary arterial and chronic thromboembolic hypertension.

Authors:  Stéphanie Saxer; Mona Lichtblau; Charlotte Berlier; Elisabeth D Hasler; Esther I Schwarz; Silvia Ulrich
Journal:  Lung       Date:  2019-07-01       Impact factor: 2.584

Review 4.  Diagnosis, Evaluation and Treatment of Pulmonary Arterial Hypertension in Children.

Authors:  Benjamin S Frank; D Dunbar Ivy
Journal:  Children (Basel)       Date:  2018-03-23

5.  A phenotype of increased sleepiness in a mouse model of pulmonary hypertension and right ventricular hypertrophy.

Authors:  Eric M Davis; Jeffrey J Baust; Brett J O'Donnell; Faraaz A Shah; Angela McDowell; Lanping Guo; Christopher P O'Donnell
Journal:  PLoS One       Date:  2018-12-07       Impact factor: 3.240

6.  My life with pulmonary arterial hypertension: a patient perspective.

Authors:  Pisana Ferrari; Hall Skåra
Journal:  Eur Heart J Suppl       Date:  2019-12-17       Impact factor: 1.803

7.  Novel composite clinical endpoints and risk scores used in clinical trials in pulmonary arterial hypertension.

Authors:  Olivier Sitbon; Sylvia Nikkho; Raymond Benza; Chunqin Cq Deng; Harrison W Farber; Mardi G Maitland; Paul Hassoun; Christian Meier; Joanna Pepke-Zaba; Krishna Prasad; Werner Seeger; Paul A Corris
Journal:  Pulm Circ       Date:  2020-11-18       Impact factor: 3.017

8.  Association of daily physical activity with psychosocial aspects and functional capacity in patients with pulmonary arterial hypertension: a cross-sectional study.

Authors:  Layse Nakazato; Felipe Mendes; Ilma A Paschoal; Daniela C Oliveira; Marcos M Moreira; Mônica C Pereira
Journal:  Pulm Circ       Date:  2021-03-29       Impact factor: 3.017

9.  Physical activity and its clinical correlates in chronic thromboembolic pulmonary hypertension.

Authors:  Cristine Schmidt; Miguel Monteiro; Inês Furtado; Luísa Carvalho; Fabienne Gonçalves; Abílio Reis; Mário Santos
Journal:  Pulm Circ       Date:  2022-05-03       Impact factor: 2.886

Review 10.  Increasing quality of life in pulmonary arterial hypertension: is there a role for nutrition?

Authors:  Paulien Vinke; Suzanne M Jansen; Renger F Witkamp; Klaske van Norren
Journal:  Heart Fail Rev       Date:  2018-09       Impact factor: 4.214

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.